Tiffany Tran
Physician Assistant · Honolulu, HINPI 1740959600
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Gilead at 38.0% of the total. 2025 is the largest year on record at $2,398, more than ten times the $20 reported in 2022. Among physician assistant clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $40.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Viiv Healthcare Company$922
- AbbVie$718
- Madrigal Pharmaceuticals$328
- Novo Nordisk$253
- Boehringer Ingelheim$233
- plus $1K from 16 others
What the payments were for
- Food & beverage$5,799100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 55 | $2,203 |
| Viiv Healthcare Company | 15 | $922 |
| AbbVie | 24 | $718 |
| Madrigal Pharmaceuticals | 4 | $328 |
| Novo Nordisk | 3 | $253 |
| Boehringer Ingelheim | 9 | $233 |
| Merck | 9 | $215 |
| E.r. Squibb & Sons, L.L.C. | 2 | $161 |
| Neurocrine Biosciences, Inc. | 1 | $140 |
| Novartis | 5 | $135 |
| Abbott | 1 | $129 |
| Indivior Inc. | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Johnson & Johnson | 2 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| GSK | 1 | $28 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| Bayer | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,799 in reported general payments places this provider in the 95th percentile of 246 physician assistant providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 16 | $51,125 |
| TrulicityDulaglutide | 23 | $33,322 |
| OzempicSemaglutide | 18 | $21,263 |
| JardianceEmpagliflozin | 13 | $15,029 |
| MounjaroTirzepatide | 12 | $12,590 |
| Risperdal ConstaRisperidone Microspheres | 18 | $4,892 |
| Atorvastatin Calcium | 143 | $1,554 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,359 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $975 |
| Losartan Potassium | 85 | $692 |
| Amlodipine Besylate | 71 | $617 |
| Metoprolol Succinate | 31 | $533 |
| Omeprazole | 21 | $449 |
| Rosuvastatin Calcium | 22 | $349 |
| Alendronate Sodium | 18 | $303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $39 | $56,01734 claims |
| Novo NordiskOzempic | $253 | $21,26318 claims |
| Boehringer IngelheimJardiance | $233 | $15,02913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 246 physician assistant providers in Hawaii.
Other physician assistant in Honolulu
- Eric YukumotoHonolulu$41K
- Dorothy MauriceHonolulu$39K
- Joycelyn ChunHonolulu$11K
- Rachel InouyeHonolulu$11K
- Timothy HowardHonolulu$10K
- Jamie TamayoseHonolulu$5K
- Rory RuskovichHonolulu$5K
- Nicole EvansHonolulu$5K
- Ayanna JoseHonolulu$4K
- Christopher AcreeHonolulu$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.